RECURRENT ACUTE BIPHENOTYPIC LEUKEMIA

Clinical trials for RECURRENT ACUTE BIPHENOTYPIC LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT ACUTE BIPHENOTYPIC LEUKEMIA trials appear

Sign up with your email to follow new studies for RECURRENT ACUTE BIPHENOTYPIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Terminated 2

Oral combo aims to tame aggressive leukemia in patients out of options

Disease control Ongoing

This study is testing whether two oral cancer drugs, venetoclax and decitabine, can help control a fast-growing blood cancer called acute myeloid leukemia (AML) in adults for whom prior treatments have stopped working. The goal is to see if this combination can reduce cancer cell…

Matched conditions: RECURRENT ACUTE BIPHENOTYPIC LEUKEMIA

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

RECURRENT ACUTE BIPHENOTYPIC LEUKEMIA

Get alerted when new RECURRENT ACUTE BIPHENOTYPIC LEUKEMIA trials appear

Oral combo aims to tame aggressive leukemia in patients out of options